Peter Lio, MD, FAAD
Disclosures: Speakers Bureau-Sanofi Genzyme Regeneron|Speakers Bureau-Pfizer, Inc.|Speakers Bureau-AbbVie|Speakers Bureau-Eli Lilly and Company|Speakers Bureau-Galderma|Speakers Bureau-Incyte|Speakers Bureau-L'Oreal|Advisor-Almirall|Advisor-ASLAN|Advisor-Bristol-Meyers Squbb|Advisor-Concerto|Advisor-Dermavant|Advisor-Micreos|Advisor-Castle|Advisor-Hyphens Pharma|Advisor-Boston Skin Science|Advisor-Unilever|Advisor-Theraplex|Advisor-Altus Labs|Advisor-Verrica|Advisor-SkinFix|Consulting Fee-Kimberly-Clark|Independent Contractor (included contracted research)-AOBiome (Relationship has ended)|Independent Contractor (included contracted research)-AbbVie (Relationship has ended)|Independent Contractor (included contracted research)-Regeneron Sanofi Genzyme (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Micreos|Stocks or stock options, excluding diversified mutual funds-Altus Labs - 09/15/2022

Peter Lio Bio

 

Peter Lio, MD is a Clinical Assistant Professor of Dermatology & Pediatrics at Northwestern University Feinberg School of Medicine. Dr. Lio received his medical degree from Harvard Medical School, completed his internship in Pediatrics at Boston Children’s Hospital, and his Dermatology training at Harvard where he served as Chief Resident in Dermatology. While at Harvard, he received formal training in acupuncture. Dr. Lio is the founding director of the Chicago Integrative Eczema Center and a founding partner of Medical Dermatology Associates of Chicago. He serves as a board member and scientific advisory committee member emeritus for the National Eczema Association. He is a member of the American Academy of Dermatology’s Atopic Dermatitis Expert Resource Group and a founding faculty member of the Integrative Dermatology Certificate Program. He has over 200 publications and 3 textbooks.